Based on that RNA-Seq results, data analysis with annotated clinical data of the SEQC-498-RPM data set demonstrates that RET is expressed in NB patients of all four International Neuroblastoma Staging System Committee (INSS) stages, and RET has higher expression levels in stage 4 metastatic subgroup compared with other groups (Figure 1A). The gene discussed is RET; the disease is neuroblastoma.